
Fibroid Surgery Breakthrough: Why LAAM® and DualPortGYN® Are Outperforming Robotic and Open Procedures
ROCKVILLE, Md., June 10, 2025 /PRNewswire/ — Women now have access to a superior alternative for fibroid removal: hyper-specialist surgery that eliminates even the largest and most complex fibroids—without the risks, recovery time, or high costs of robotic, open, or embolization procedures. The Center for Innovative GYN Care (CIGC) is a nationally recognized leader in minimally invasive gynecologic surgery, offering advanced care with unmatched outcomes.
'We see women who've been told their only option is open surgery,' said Dr. Natalya Danilyants, board-certified GYN surgeon and director of CIGC. 'Yet with our advanced techniques, we remove even the largest fibroids through tiny incisions—no required hospital stay, no long recovery. Patients go home the same day and finally get real relief.'
CIGC's LAAM® (Laparoscopically Assisted Abdominal Myomectomy) and DualPortGYN® techniques offer unmatched results. Unlike robotic or traditional laparoscopic methods, which are limited by fibroid size or uterine access, CIGC surgeons operate through two tiny incisions, minimizing scarring, complications and preserving fertility.
'Post-surgery my recovery was remarkable,' said a CIGC patient on June 3, 2025. 'Every stage from the initial consultation to my discharge was seamlessly executed.'
Another patient was recently prescribed open surgery due to the extremely large size of her fibroids. Instead, she turned to CIGC—and her fibroid was successfully removed through LAAM®. She went home that day, with minimal discomfort, and returned to normal activity within 10 days.
No other approach offers:
Immediate symptom relief within one hour
Fertility preservation by protecting the uterus, cervix, and ovaries
Fastest recovery (10–14 days vs. up to 3 weeks for robotic or standard laparoscopic, and up to 8 weeks for open surgery)
No hospital stay—performed at our outpatient surgery centers with dedicated care teams in Maryland and New Jersey
Many women are offered outdated or unnecessary procedures. Embolization can delay symptom relief and even increase the risk of miscarriage. Robotic and open surgeries involve longer recoveries, more pain, and higher costs.
CIGC's approach is the new superior standard for fibroid removal—and it's available now: https://innovativegyn.com/landing/fibroids/
About The Center for Innovative GYN Care (CIGC)
Since 2008, CIGC's board-certified surgeons have delivered advanced, minimally invasive GYN surgery using laparoscopic techniques that result in faster recovery, less pain, and fewer complications. Our procedures are performed at our specialized outpatient centers in Maryland and New Jersey, which provide dedicated nursing teams to each patient, and we participate with many major insurance plans. We welcome patients from across the country and around the world, offering both in-person and virtual consultations.
Media Contact: Jasmin Ramseysocial@innovativegyn.com 1 888-787-4379, opt 1
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Sun
6 hours ago
- The Sun
Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
SINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious chronic diseases, has announced the availability of Wegovy® (semaglutide 2.4mg) in Singapore. Wegovy® (semaglutide 2.4mg) is a once-weekly injectable treatment indicated for chronic weight management in adults and adolescents (aged 12 and above) living with obesity (BMI ≥30 kg/m²), or who are overweight (BMI ≥27 kg/m² to <30 kg/m²) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia1. It is used alongside a reduced-calorie diet and increased physical activity, supporting Singapore's efforts to improve population health. The treatment works by addressing one of the underlying biological drivers of obesity. Wegovy® (semaglutide 2.4mg) is a GLP-1 receptor agonist with 94% similarity to the body's natural GLP-1 hormone. It activates receptors involved in appetite regulation, helping individuals feel full sooner and reduce food intake1. This mechanism supports weight loss when combined with sustainable lifestyle changes. The availability of Wegovy® (semaglutide 2.4mg) comes as obesity continues to pose a significant health burden in Singapore. An estimated 600,000 adults are currently living with obesity2-4, a condition associated with more than 200 health complications5. Despite its prevalence and medical complexity, obesity remains heavily stigmatised—often misunderstood as merely the result of poor personal choices. Individuals living with obesity frequently face discrimination and mental health challenges which further isolate them. This misplaced blame, rather than targeting the disease itself, creates barriers to and slows the advancement of effective obesity treatment. Recognised by World Health Organization as a chronic disease6, obesity requires compassionate evidence-based care. The launch of Wegovy® (semaglutide 2.4mg) in Singapore provides a new treatment option for weight management available through private prescription. Dr Abel Soh, Abel Soh Diabetes, Thyroid and Endocrine Clinic and Chairperson for Endocrine and Metabolic Society of Singapore (EMSS) stated, 'Obesity is not simply the result of lifestyle choices — it is a medically recognised chronic disease influenced by a complex interplay of genetics, hormones, and environment. In my clinical practice, I see firsthand how many individuals blame themselves when in fact, their biology is often working against them. It's time we shift the conversation from blame to support in the management of individuals with obesity' Lifestyle factors in Singapore further contribute to the challenge. In Singapore's demanding work culture—where full-time employees work an average of 44.6 hours per week7, with time constraints and fatigue frequently cited as barriers to maintaining regular physical activity. These circumstances underscore the importance of comprehensive treatment strategies that facilitate the adoption of healthier lifestyles, including increased physical activity and a reduced-calorie diet, as integral components of long-term weight management. Mr Vincent Siow, General Manager, Novo Nordisk Singapore, said 'With treatments like Wegovy® (semaglutide 2.4mg) now available in Singapore, we have an opportunity to provide healthcare professionals with more evidence-based options to support their patients in regaining control of their health and improving long-term outcomes.' References: 1. Wegovy Singapore Prescribing Information, February 2025 2. Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508. 3. World Obesity. Retrieved from 4. World Obesity. Retrieved from 5. Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93(3):351-359 2. CDC, Cancers Associated with Overweight and Obesity Makeup 40 percent of Cancers Diagnosed in the United States. Available at 6. World Health Organization. (2024). Obesity and As accessed on 22nd May 2025. 7. Leu J, Rebello SA, Sargent GM, Kelly M, Banwell C. Hard work, long hours, and Singaporean young adults' health. A qualitative study. Frontiers in Public Health. 2023; 11. Hashtag: #NovoNordisk #Wegovy The issuer is solely responsible for the content of this announcement.


Malaysian Reserve
14 hours ago
- Malaysian Reserve
Master Injector Alexander Tirado Brings Passion and Knowledge as New Wellness Director at Parkland Medspa and Wellness Center
PARKLAND, Fla., July 11, 2025 /PRNewswire/ — Master injector Alexander Tirado, who brings unmatched passion and intimate knowledge of multiple disciplines, has been appointed as the Wellness Director of the revitalized Parkland Medspa and Wellness Center and Las Olas Medspa in Fort Lauderdale. He has also been selected to be a regional clinical trainer for the Cellular Medicine Association (CMA), which uses an innovative approach to sexual health led by the renowned Dr. Charles Runels. Tirado, PA-C, has been a member of the CMA since 2016. He is currently a CMA-Certified Instructor for the Use of Platelet-Rich Plasma and other Cellular Strategies for the Vampire Procedures, O-Shot®, Priapus Shot®, Hair Growth, Scars, and more. 'Dr. Charles Runels, the pioneer of the O-Shot (Orgasm Shot) and P-Shot (Priapus Shot) has recognized my 14 years of performing these procedures and my excellence in sexual wellness,' said Tirado, who previously worked with Liquivida in Fort Lauderdale and owned Alexander Medspa for 10 years. 'The satisfaction and increased confidence that patients have after these treatments are extremely rewarding.' The Parkland Medspa and Wellness Center is one of the few facilities in South Florida to be certified to perform the O-Shot and P-Shot procedures, according to Tirado. The multi-cultural Tirado is a Board-certified Physician Assistant with more than 14 years of expertise as a Master Injector and a renowned leader in Aesthetics, Functional Medicine, and Regenerative Medicine. Tirado is well-respected in the industry for utilizing dermal fillers to rejuvenate cheeks, redefine the jawline, and enhance the lips to provide a more youthful appearance. 'When patients combine aesthetics treatments with wellness care, they will look and feel younger and more revitalized,' said Tirado, who enjoys teaching people how to get healthier and get younger. 'We go to the root of the problem. One of my specialties is functional medicine, which includes regenerative medicine and hormone therapy.' Tirado added that hormone therapy is a passion of his. 'Hormone therapy is the future,' added Tirado. 'You feel refreshed. Functional medicine and regenerative medicine are also focuses of mine within wellness.' Tirado uses a comprehensive 25-point hormone therapy questionnaire that allows him to tailor treatments to everyone's unique needs, targeting symptoms like fatigue, brain fog, joint pain, decreased libido, and mood imbalances. 'As a Wellness Director, I believe that true wellness requires addressing the whole person — body, mind, and spirit,' said Tirado. 'Our goal is to provide personalized, compassionate care that empowers patients to regain control of their health and youthful appearance.' Parkland Medspa and Wellness Center has rejuvenated and modernized the space that was previously occupied by Natura Medspa and Aesthetics Clinique in the Riverstone Shoppes. Parkland Medspa and Wellness Center has brought together multiple master injectors and leading experts in Wellness and Rejuvenative Medicine with a shared commitment to excellence and a passion for personalized service. It is located at 7383 N. State Road 7, just north of Hillsboro Blvd, in the Riverstone Shoppes. Call 877-2-Parkland (877-272-7552) to make an appointment. The Fort Lauderdale office is located at 888 E. Las Olas Blvd, Suite 110. Call 954-906-3373 for an appointment.


Malaysian Reserve
a day ago
- Malaysian Reserve
Chinese Orthodontic Expertise Featured in JAO's Coverage of DGAO 2024
——Professor Gang Shen's Mandibular Repositioning Protocol Highlighted in JAO's Summary of Leading Presentations at the German Aligner Congress COLOGNE, Germany, July 11, 2025 /PRNewswire/ — The Journal of Aligner Orthodontics (JAO), a leading international publication in the field, recently published a comprehensive summary of keynote presentations delivered at the 8th Congress of the German Association for Aligner Orthodontics (DGAO), held in Cologne in November 2024. Among the featured speakers was Professor Gang Shen, Chief R&D Scientist of Smartee Denti-Technology and Executive President of Taikang Bybo Dental Group, whose clinical approach to mandibular repositioning therapy drew particular attention for its structured methodology and non-surgical success in treating Class II skeletal malocclusions. According to JAO's summary, Professor Shen opened his keynote by introducing his diagnostic concept of 'three-depth malocclusion', a complex condition defined by: retrusive mandible, increased facial convexity, excessive overjet, deep overbite, a pronounced curve of Spee, and a Class II molar relationship. JAO highlighted the clinical challenge of treating such cases in adult patients, where orthognathic surgery is often clinically indicated but often declined by patients, and conventional treatments like maxillary distalization or premolar extractions have limited applicability. To overcome these limitations, Professor Shen proposed an orthopedic treatment approach using Smartee's S8-SGTB clear aligner system. The protocol is a two-phase treatment strategy, beginning with mandibular repositioning, achieved through the combination of vertical bite blocks and guided anterior mandibular advancement using the S8-SGTB appliance. In the subsequent phase, once the mandible has been repositioned, aligners are used to guide incisor intrusion and molar extrusion, optimizing occlusal relationships. The mandibular advancement also promotes adaptive bone remodeling in the posterior region of The vertical tooth movements are controlled via the aligner system, not directly caused by mandibular advancement itself. As emphasized in the JAO article, Professor Shen underscored that temporomandibular joint (TMJ) remodeling remains biologically viable even in adults, making effective repositioning feasible beyond adolescence. He also outlined a four-step simulation protocol to determine and record the optimal mandibular advancement position: 1. Complete an intraoral scan to record the patient's dentition anatomical structures.2. Perform a repositioning simulation to define the new jaw position3. Use wax registration to secure the position4. Take a posterior occlusal scan to digitally capture the final mandibular postureNote: The construction bite should maintain a 5 mm posterior clearance. The documented success of Smartee's GS system, with over 100,000 clinical applications to date, further validates its scalability, precision, and non-invasive treatment potential. To learn more about Smartee's Mandibular Repositioning Technology and explore case examples, visit: Photo – View original content: